Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mismatched gonorrhea results

This article was originally published in The Gray Sheet

Executive Summary

Roche Diagnostics is recalling Tecan clinical workstations used with the Amplicor CT/NG test for detection of chlamydia and gonorrhea due to a software error that could cause a mismatch among patient samples and test results. Separately, Roche notes there have been reports of the Amplicor system formulating similarly discordant results because information in the workstation's data management system had not been expunged properly. In both cases, no patient results have been adversely affected, the firm says...

You may also be interested in...



Tecan Clinical Workstation Recall Addressed Via Field Correction Of 44 Units

A Class I recall of 44 Tecan clinical workstations will be resolved through a field correction to upgrade the systems' software, the firm says

‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation

CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.

Biogen Sees Improving Momentum In Slow Leqembi Launch

Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020241

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel